Akorn Return on Equity

Akorn (AKRX) currently reports a ROE of 2058.66%. That is above the Healthcare sector average of 11.15%. Use the charts on this page to explore Akorn's ROE history and peer comparisons.

Akorn's ROE of 2058.66% is higher than the Healthcare sector average of 11.15%. That is roughly 18356.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Akorn's current 2058.66% should be judged against Healthcare norms (sector average: 11.15%) and against AKRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 2058.66%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.15%. From there, open related valuation or income-statement pages for Akorn, and consider following AKRX for alerts when major investors trade the stock.

Akorn is classified in the Healthcare sector. On ROE, it currently shows 2058.66% versus a sector average near 11.15%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AKRX with unrelated industries.